We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Strength Seen in Acme United (ACU): Can Its 5.0% Jump Turn into More Strength?
Read MoreHide Full Article
Acme United Corporation. (ACU - Free Report) shares ended the last trading session 5% higher at $46. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 1% loss over the past four weeks.
Acme United is demonstrating resilience and operational discipline, successfully navigating tariff-driven disruptions while maintaining steady growth and improving profitability. The company’s expanding presence in first aid and medical products, combined with strong international momentum and recent strategic acquisitions of My Medic, positions it to capture incremental market share and diversify its revenue base.
This company is expected to post quarterly earnings of $0.55 per share in its upcoming report, which represents a year-over-year change of +34.2%. Revenues are expected to be $47.1 million, up 2.5% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Acme United, the consensus EPS estimate for the quarter has been revised 1.8% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ACU going forward to see if this recent jump can turn into more strength down the road.
Acme United belongs to the Zacks Consumer Products - Discretionary industry. Another stock from the same industry, Interparfums (IPAR - Free Report) , closed the last trading session 0.3% lower at $91.2. Over the past month, IPAR has returned -10.5%.
For Interparfums, the consensus EPS estimate for the upcoming report has changed -3.4% over the past month to $1.14. This represents a change of -13.6% from what the company reported a year ago. Interparfums currently has a Zacks Rank of #2 (Buy).
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Strength Seen in Acme United (ACU): Can Its 5.0% Jump Turn into More Strength?
Acme United Corporation. (ACU - Free Report) shares ended the last trading session 5% higher at $46. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 1% loss over the past four weeks.
Acme United is demonstrating resilience and operational discipline, successfully navigating tariff-driven disruptions while maintaining steady growth and improving profitability. The company’s expanding presence in first aid and medical products, combined with strong international momentum and recent strategic acquisitions of My Medic, positions it to capture incremental market share and diversify its revenue base.
This company is expected to post quarterly earnings of $0.55 per share in its upcoming report, which represents a year-over-year change of +34.2%. Revenues are expected to be $47.1 million, up 2.5% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Acme United, the consensus EPS estimate for the quarter has been revised 1.8% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ACU going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Acme United belongs to the Zacks Consumer Products - Discretionary industry. Another stock from the same industry, Interparfums (IPAR - Free Report) , closed the last trading session 0.3% lower at $91.2. Over the past month, IPAR has returned -10.5%.
For Interparfums, the consensus EPS estimate for the upcoming report has changed -3.4% over the past month to $1.14. This represents a change of -13.6% from what the company reported a year ago. Interparfums currently has a Zacks Rank of #2 (Buy).